Pharma BD Deal Intelligence
Ranks computed across 828 graded deals (Critic + Outcome Score both present).
Medtronic acquired Covidien for $42.9 billion in cash and stock, creating one of the world's largest medical device companies. The deal combined Medtronic's cardiac and spinal surgery expertise with Covidien's surgical supplies and vascular products.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Medtronic plc / Covidien plc (this deal) | 2014 | $42.9B | 65 |
| Thermo Fisher Scientific Inc. / Life Technologies Corporation | 2013 | $15.1B | 84 |
| Merck KGaA / Sigma-Aldrich Corporation | 2014 | $17.0B | 80 |
| Becton, Dickinson and Company / C.R. Bard Inc. | 2017 | $24.0B | 77 |
| Johnson & Johnson / Synthes Inc. | 2011 | $19.7B | 77 |
| Thermo Fisher Scientific Inc. / PPD Inc. | 2021 | $17.4B | 77 |
| Danaher Corporation / GE Life Sciences Biopharma Business (now Cytiva) | 2019 | $21.4B | 76 |